LW6 enhances chemosensitivity to gemcitabine and inhibits autophagic flux in pancreatic cancer
Open Access
- 1 November 2019
- journal article
- research article
- Published by Elsevier in Journal of Advanced Research
- Vol. 20, 9-21
Abstract
No abstract availableKeywords
Funding Information
- China Scholarship Council (201608080159)
- Deutsche Forschungsgemeinschaft (321137804, ZE 712/1-1, VO 450/15-1)
This publication has 36 references indexed in Scilit:
- Inflammation, Autophagy, and Obesity: Common Features in the Pathogenesis of Pancreatitis and Pancreatic CancerGastroenterology, 2013
- Chemotherapy and autophagy-mediated cell death in pancreatic cancer cellsPancreatology, 2012
- LW6, a novel HIF-1 inhibitor, promotes proteasomal degradation of HIF-1α via upregulation of VHL in a colon cancer cell lineBiochemical Pharmacology, 2010
- The role of autophagy in the treatment of pancreatic cancer with gemcitabine and ionizing radiationInternational Journal of Oncology, 2010
- Dual Role of 3-Methyladenine in Modulation of Autophagy via Different Temporal Patterns of Inhibition on Class I and III Phosphoinositide 3-KinaseJournal of Biological Chemistry, 2010
- Modifications in P62 occur due to proteasome inhibition in alcoholic liver diseaseLife Sciences, 2005
- Lysosomal Turnover, but Not a Cellular Level, of Endogenous LC3 is a Marker for AutophagyAutophagy, 2005
- Methods for monitoring autophagyThe International Journal of Biochemistry & Cell Biology, 2004
- Transcriptional activation of p62/A170/ZIP during the formation of the aggregates: possible mechanisms and the role in Lewy body formation in Parkinson's diseaseBrain Research, 2004
- In Vivo Analysis of Autophagy in Response to Nutrient Starvation Using Transgenic Mice Expressing a Fluorescent Autophagosome MarkerMolecular Biology of the Cell, 2004